Puma Biotechnology Aktie - PBYI

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

3,00

Gebot

2,81

Fragen

3,91

Volumen

545.060

2,94 Tagesbereich 3,07

2,225 52-Wochen-Bereich 7,73

Marktkapitalisierung

147,263M

Handelsende

3,02

Handelsbeginn

3,03

Letzte Trade

933

(formt)

Letzter Handelszeitpunkt

Finanzvolumen

US$ 1.634.491

VWAP

2,9987

Durchschnittliches Volumen (3 Mio.)

608.285

Ausgegebene Aktien

49.087.684

Dividendenrendite

Kurs-Gewinn-Verhältnis

6,73

Gewinn pro Aktie (EPS)

0,44

Erlöse

235,64M

Nettogewinn

21,59M

Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.pumabiotechnology.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Puma Biotechnology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PBYI. The last closing price for Puma Biotechnology was US$3,02. Over the last year, Puma Biotechnology shares have traded in a share price range of US$ 2,225 to US$ 7,73.

Puma Biotechnology currently has 49.087.684 shares in issue. The market capitalisation of Puma Biotechnology is US$148,24 million. Puma Biotechnology has a price to earnings ratio (PE ratio) of 6.73.

Form 4 - Statement of changes in beneficial ownership of securities

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 2, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement...

Form 144 - Report of proposed sale of securities

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®...

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on December 2, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of an...

Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the initiation of its ALISertib in CAncer (ALISCA™-Breast1) Phase II trial (PUMA-ALI-1201; NCT06369285) of...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.51	-14.5299145299	3.51	3.6	2.96	801964	3.11629521	CS
4	0.24	8.69565217391	2.76	4.06	2.73	881263	3.24536207	CS
12	0.2	7.14285714286	2.8	4.06	2.32	608285	3.09242947	CS
26	-0.97	-24.4332493703	3.97	4.13	2.225	446184	3.03009682	CS
52	-2.58	-46.2365591398	5.58	7.73	2.225	487552	4.0262322	CS
156	0.35	13.2075471698	2.65	7.73	1.6	373020	3.57263918	CS
260	-5.95	-66.4804469274	8.95	15	1.6	527940	6.99996639	CS

PBYI - Frequently Asked Questions (FAQ)

What is the current Puma Biotechnology share price?

The current share price of Puma Biotechnology is US$ 3,00

How many Puma Biotechnology shares are in issue?

Puma Biotechnology has 49.087.684 shares in issue

What is the market cap of Puma Biotechnology?

The market capitalisation of Puma Biotechnology is USD 148,24M

What is the 1 year trading range for Puma Biotechnology share price?

Puma Biotechnology has traded in the range of US$ 2,225 to US$ 7,73 during the past year

What is the PE ratio of Puma Biotechnology?

The price to earnings ratio of Puma Biotechnology is 6,73

What is the cash to sales ratio of Puma Biotechnology?

The cash to sales ratio of Puma Biotechnology is 0,62

What is the reporting currency for Puma Biotechnology?

Puma Biotechnology reports financial results in USD

What is the latest annual turnover for Puma Biotechnology?

The latest annual turnover of Puma Biotechnology is USD 235,64M

What is the latest annual profit for Puma Biotechnology?

The latest annual profit of Puma Biotechnology is USD 21,59M

What is the registered address of Puma Biotechnology?

The registered address for Puma Biotechnology is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Puma Biotechnology website address?

The website address for Puma Biotechnology is www.pumabiotechnology.com

Which industry sector does Puma Biotechnology operate in?

Puma Biotechnology operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
BTCTBTC Digital Ltd	US$ 8,2697 (73,73%)	61,45M
BDMDBaird Medical Investment Holdings Ltd	US$ 8,80 (62,36%)	18,63M
CRKNCrown Electrokinetics Corporation	US$ 0,1235 (54,96%)	764,86M
NUKKNukkleus Inc	US$ 29,97 (45,98%)	19,09M
GSITGSI Technology	US$ 3,97 (44,36%)	87,7M
DOGZDogness International Corporation	US$ 18,23 (-58,77%)	740,45k
ORKTOrangeKloud Technology Inc	US$ 3,02 (-24,88%)	21,08M
PMAXPowell Max Ltd	US$ 0,6364 (-23,31%)	4,17M
LGCBLinkage Global Inc	US$ 0,2876 (-22,27%)	890,66k
YYAIConnexa Sports Technologies Inc	US$ 0,8299 (-20,20%)	602,48k
CRKNCrown Electrokinetics Corporation	US$ 0,1235 (54,96%)	764,86M
GCTKGlucoTrack Inc	US$ 0,0852 (15,45%)	465,22M
RIMEAlgorhythm Holdings Inc	US$ 0,0406 (-4,02%)	387,23M
TGLTreasure Global Inc	US$ 0,2459 (14,75%)	267,1M
NVDANVIDIA Corporation	US$ 137,71 (3,10%)	201,4M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Puma Biotechnology Inc (PBYI) Börsenkurse

Puma Biotechnology Inc (PBYI)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Puma Biotechnology Inc

PBYI Neueste Nachrichten

PBYI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen